Skip to content

Effect of subconjunctival Healaflow® in filtrating surgery with Preserflo® MicroShunt in Primary Open Angle Glaucoma

Effect of subconjunctival Healaflow® in filtrating surgery with Preserflo® MicroShunt in Primary Open Angle Glaucoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00037484
Enrollment
45
Registered
2025-08-01
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H40.1

Interventions

Group 1: Microshunt+Healaflow Patients’ spherical equivalents were obtained by the auto refractometer Nidek AR-1s (Oculus GmbH, Wetzlar, Germany). Intraocular pressure was obtained using Goldmann appl

Sponsors

Ludwig Maximilians Universität München
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria include patients with moderate to severe POAG requiring treatment due to inadequate intraocular pressure despite local pressure-lowering therapy or with eye drop intolerance with or without previous (MIGS) surgery. Exclusion criteria include combined procedure with cataract surgery, silicone oil tamponade, partner eye already included in the study, age younger than 18, selective laser trabeculoplasty within the last 90 days preoperatively.

Exclusion criteria

Exclusion criteria: Exclusion criteria include combined procedure with cataract surgery, silicone oil tamponade, partner eye already included in the study, age younger than 18, selective laser trabeculoplasty within the last 90 days preoperatively.

Design outcomes

Primary

MeasureTime frame
Intraocular presssure Intraocular pressure was measured using a Goldmann applanation tonometer. Measurements were taken two days, 1–2 weeks, 4–6 weeks, 3–4 months, and 5–6 months after surgery.

Secondary

MeasureTime frame
Medication The number of intraocular pressure-lowering eye drops was asked during each visit. The visits took place two days, 1–2 weeks, 4–6 weeks, 3–4 and 5–6 months after the operation.

Countries

Germany

Contacts

Public ContactLeonie Keidel

Ludwig Maximilians Universität München

leonie.keidel@med.uni-muenchen.de0049440053717

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026